MedTrace Logo

Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone

NCT02993744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2017-05-30

No results posted yet for this study

Summary

It is the aim of this study to detect the effect of Betamethasone on the maternal inflammatory parameters C-reactive protein (CRP) and leukocytes of a pregnant woman under threat of preterm delivery, for example because of a cervical infection.

Conditions

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Maria Kastanek · Medical University Vienna

  • Florian Frommlet, DI. Dr. · Medical University Vienna

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02993744 on ClinicalTrials.gov